Effect of an 18-Month Meditation Training on Regional Brain Volume and Perfusion in Older Adults: The Age-Well Randomized Clinical Trial.

Valentin Ourry, Natalie L Marchant, Géraldine Poisnel, Fabienne Collette, Denis Vivien, Vincent de La Sayette, Patrik Vuilleumier, Eglantine Ferrand Devouge, Anne Quillard, Anne Chocat, Géraldine Rauchs, Brigitte Landeau, Julie Gonneaud, Francesca Felisatti, Gael Chételat, Cassandre Palix, Claire André, Sophie Dautricourt, Edelweiss Touron, Inès Moulinet, Elizabeth Kuhn, Florence Mézenge, Eider M Arenaza-Urquijo, Marco Schlosser, Julien Asselineau, Eric Frison, Olga Klimecki, Antoine Lutz

Journal: JAMA neurology 2022;79(11):1165-1174

PMID: 36215061

Abstract

IMPORTANCE

No lifestyle-based randomized clinical trial directly targets psychoaffective risk factors of dementia. Meditation practices recently emerged as a promising mental training exercise to foster brain health and reduce dementia risk.

OBJECTIVE

To investigate the effects of meditation training on brain integrity in older adults.

DESIGN, SETTING, AND PARTICIPANTS

Age-Well was a randomized, controlled superiority trial with blinded end point assessment. Community-dwelling cognitively unimpaired adults 65 years and older were enrolled between November 24, 2016, and March 5, 2018, in France. Participants were randomly assigned (1:1:1) to (1) an 18-month meditation-based training, (2) a structurally matched non-native language (English) training, or (3) no intervention arm. Analysis took place between December 2020 and October 2021.

INTERVENTIONS

Meditation and non-native language training included 2-hour weekly group sessions, practice of 20 minutes or longer daily at home, and 1-day intensive practices.

MAIN OUTCOMES AND MEASURES

Primary outcomes included volume and perfusion of anterior cingulate cortex (ACC) and insula. Main secondary outcomes included a global composite score capturing metacognitive, prosocial, and self-regulatory capacities and constituent subscores.

RESULTS

Among 137 participants (mean [SD] age, 69.4 [3.8] years; 83 [60.6%] female; 54 [39.4%] male) assigned to the meditation (n = 45), non-native language training (n = 46), or no intervention (n = 46) groups, all but 1 completed the trial. There were no differences in volume changes of ACC (0.01 [98.75% CI, -0.02 to 0.05]; P = .36) or insula (0.01 [98.75% CI, -0.02 to 0.03]; P = .58) between meditation and no intervention or non-native language training groups, respectively. Differences in perfusion changes did not reach statistical significance for meditation compared with no intervention in ACC (0.02 [98.75% CI, -0.01 to 0.05]; P = .06) or compared with non-native language training in insula (0.02 [98.75% CI, -0.01 to 0.05]; P = .09). Meditation was superior to non-native language training on 18-month changes in a global composite score capturing attention regulation, socioemotional, and self-knowledge capacities (Cohen d, 0.52 [95% CI, 0.19-0.85]; P = .002).

CONCLUSIONS AND RELEVANCE

The study findings confirm the feasibility of meditation and non-native language training in elderly individuals, with high adherence and very low attrition. Findings also show positive behavioral effects of meditation that were not reflected on volume, and not significantly on perfusion, of target brain areas.

TRIAL REGISTRATION

ClinicalTrials.gov Identifier: NCT02977819.

Address: Normandie Univ, UNICAEN, INSERM, U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Institut Blood and Brain @ Caen-Normandie, Cyceron, France.; Lyon Neuroscience Research Center INSERM U1028, CNRS UMR5292, Lyon 1 University, Lyon, France.; Swiss Center for Affective Sciences, Department of Neuroscience, University of Geneva Medical School, Geneva, Switzerland.; EUCLID/F-CRIN Clinical Trials Platform, INSERM, CHU Bordeaux, University of Bordeaux, CIC1401-EC, Bordeaux, France.; Division of Psychiatry, University College London, London, United Kingdom.; Department of Psychology, Faculty of Psychology and Educational Sciences, University of Geneva, Geneva, Switzerland.; Barcelonabeta Brain Research Center, Fundación Pasqual Maragall, Barcelona, Spain.; Normandie Univ, UNIROUEN, Department of General Practice, Rouen, France.; Rouen University Hospital, CIC-CRB 1404, F 76000, Rouen, France.; CHU Caen-Normandie, Department of Neurology, Caen, France.; CHU Caen-Normandie, Department of Clinical Research, Caen, France.; GIGA-CRC, In Vivo Imaging, Université de Liège and Belgian National Fund for Scientific Research, Liège, Belgium.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.